Table 2.
Characteristics of patients with severe vs. life-threatening disease receiving COVID-19 convalescent plasma at time of transfusiona
| COVID-19 Classification | |||
|---|---|---|---|
| Severe | Life-Threatening | ||
| n = 16 | n = 15 | pb | |
| Female sex – no. (%) | 7 (44) | 3 (20) | 0.252 |
| BMI | 37.3 ± 8.4 | 37.5 ± 12.6 | 0.964 |
| Sequential Organ Failure Assessment (SOFA) Score | 0 [1.5] | 4 [2] | 0.001 |
| C-reactive protein – mg/dL | 12.0 ± 9.8 | 19.5 ± 7.6 | 0.028 |
| D-dimer – mcg/mL | 1.86 ± 3.08 | 3.55 ± 4.96 | 0.271 |
| Ferritin – ng/mL | 1469 ± 1764 | 1594 ± 1018 | 0.821 |
| In-Hospital Death – no. (%) | 0 | 4 (27%) | 0.037 |
| Length of stay – days | 9 [4] | 21.5 [25.5] | 0.012 |
aPlus-minus values are means ± SD, values with brackets are medians [interquartile range]
bFisher’s exact test, Student’s T-test, or Wilcoxon-Mann-Whitney test as appropriate